Delivery Order SPE2DB25D3012-SPE2DB25FXAHN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,596.30 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (1,000 count) on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.63 to AmerisourceBergen Drug Corp for 1,000 tablets of Metformin HCL ER 500 mg, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under a larger vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,903,179 units of Metformin HCL ER 500 mg tablets. The contract has a firm-fixed price of $7,542.17 and a period of performance through January 14, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,548.60, is a delivery order for the supply of Metformin HCL 500 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units, with a ceiling value of $1,190.00. This competitively awarded, firm fixed-price delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania location and is scheduled for completion by July 31, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.08 to AmerisourceBergen Drug Corp for the supply of Metformin HCL 500 mg tablets in quantities of 1,000 units. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement. Performance is scheduled for completion by August 21, 2025, with the product to be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units, with a ceiling value of $2,509.92. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for ultimate completion on September 10, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,513.21 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, issued one day prior on August 28, 2025. The award was made on a competitive basis with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,967.89 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025. The award was made on September 12, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under a...
- The Defense Logistics Agency (DLA) awarded a $1,102.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL 500 mg tablets (1000-count units). This non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAHNDelivery Order
The Defense Logistics Agency awarded a $1,487.16 delivery order to AmerisourceBergen Drug Corp for 500 tablets of Metformin HCL 1,000 mg, with an ultimate completion date of September 19, 2025. This non-set-aside, firm fixed-price contract represents a small-value transaction within the pharmaceutical supply chain supporting federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive portfolio of generic and brand-name medications. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The prime IDV functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceuticals and medical supplies to military healthcare programs worldwide. The company's federal contract awards demonstrate consistent capability to meet procurement requirements through competitive award processes, with this particular order fulfilling routine pharmaceutical supply needs across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/18/25 |